Avah insider plans sale of 31,600 shares

Avah Holdings has a planned sale of 31,600 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ.

Rhea-AI Filing Summary

Avah Holdings has a planned sale of 31,600 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ. The shares have an aggregate market value of $250,588.00, and the filing lists 251,676 shares of this class outstanding.

The securities to be sold were acquired on 02/14/2026 through restricted stock vesting from the issuer, totaling 89,788 shares on that date. The filing also notes a prior sale on 01/02/2026 of 34,607 shares of common stock for gross proceeds of $281,053.83.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for AVAH disclose?

The Form 144 discloses a planned sale of 31,600 shares of Avah common stock. The sale will be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $250,588.00 based on the figures in the filing.

How many AVAH shares are planned to be sold under this Form 144?

The filing shows a planned sale of 31,600 Avah common shares. These shares are listed with an aggregate market value of $250,588.00, and the transaction is slated to occur on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

When were the AVAH shares being sold acquired and how?

The shares being sold were acquired on February 14, 2026, through restricted stock vesting from the issuer. On that date, 89,788 common shares were acquired, with payment described as “Not Applicable,” consistent with a vesting rather than a cash purchase.

What prior AVAH stock sales are disclosed in the last three months?

The notice reports a sale on January 2, 2026, of 34,607 Avah common shares. That transaction generated gross proceeds of $281,053.83 and was executed through Morgan Stanley Smith Barney LLC Executive Financial Services, according to the filing details.

Which broker is handling the AVAH Form 144 stock sale?

The planned sale is being handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction is to be executed on the NASDAQ exchange.

How many AVAH shares are outstanding for this class of stock?

For the class of common stock referenced in the filing, 251,676 shares are listed as outstanding. This figure is presented in the securities information section and provides context for the 31,600 shares planned for sale under this Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 08:36 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001983702
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aveanna Healthcare Holdings, Inc.
SEC File Number	001-40362
Address of Issuer	400 INTERSTATE NORTH PARKWAY STE 1700 ATLANTA GEORGIA 30339
Phone	770-441-1580
Name of Person for Whose Account the Securities are To Be Sold	Stewart Deborah
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	31600	250588.00	251676	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/14/2026	Restricted Stock Vesting	Issuer			89788	02/14/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	Common Stock	01/02/2026	34607	281053.83

144: Remarks and Signature

Remarks	These shares will automatically be sold on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on the date of the vesting event. The sale is mandated by the Reporting Person's adoption of a Rule 10b5-1 trading plan and does not represent a discretionary trade by the Reporting Person.
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jonathan Beckler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)